Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aptose Biosciences Inc (APS.TO)

Aptose Biosciences Inc (APS.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 266,846
  • Shares Outstanding, K 88,949
  • Annual Sales, $ 0 K
  • Annual Income, $ -55,238 K
  • 60-Month Beta 1.31
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.37
Trade APS.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.62
  • Most Recent Earnings -0.13 on 11/12/21
  • Next Earnings Date 11/11/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.23
  • Number of Estimates 3
  • High Estimate -0.20
  • Low Estimate -0.25
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -4.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.51 +14.34%
on 10/27/21
3.53 -18.70%
on 11/17/21
+0.26 (+9.96%)
since 10/26/21
3-Month
2.51 +14.34%
on 10/27/21
3.91 -26.60%
on 09/02/21
-0.91 (-24.07%)
since 08/26/21
52-Week
2.51 +14.34%
on 10/27/21
9.40 -69.47%
on 12/01/20
-5.39 (-65.25%)
since 11/26/20

Most Recent Stories

More News
Aptose to Present at the Piper Sandler 33rd Annual Healthcare Conference

SAN DIEGO and TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly...

APTO : 2.28 (-5.00%)
APS.TO : 2.87 (-4.33%)
Aptose Biosciences: Q3 Earnings Snapshot

TORONTO (AP) _ Aptose Biosciences Inc. (APTO) on Thursday reported a loss of $11.3 million in its third quarter.

APS.TO : 2.87 (-4.33%)
Aptose Reports Results for the Third Quarter 2021

- Conference call and webcast at 5:00 pm ET today - - HM43239, myeloid kinome inhibitor with clinically validated activity added to pipeline - ...

APTO : 2.28 (-5.00%)
APS.TO : 2.87 (-4.33%)
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector

The $11.9 trillion global healthcare industry is in the early stages of a massive upheaval. Frustrated ...

TDOC : 109.61 (+3.41%)
NUAN : 55.34 (-0.18%)
AAPL : 156.81 (-3.17%)
BB.TO : 12.59 (-3.38%)
APS.TO : 2.87 (-4.33%)
AEZS.TO : 0.61 (-1.61%)
Aptose to Report Third Quarter 2021 Financial Results and Hold Conference Call on Thursday, November 11, 2021

SAN DIEGO and TORONTO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly...

APTO : 2.28 (-5.00%)
APS.TO : 2.87 (-4.33%)
How Robots and A.I. are About To Change This $11 Trillion Industry Forever

TikTok’s nearly 700 million users seek medical advice from random individuals and charlatans, ...

TRUE.CN : 1.300 (-7.14%)
TREIF : 1.0400 (-5.27%)
AEZS.TO : 0.61 (-1.61%)
APS.TO : 2.87 (-4.33%)
FTRP.TO : 5.15 (-3.74%)
Why A.I. Is About To Trigger The Next Great Medical Breakthrough

The healthcare industry is one of the fastest growing in the world, but today, it's seeing a major disruption. With ...

FTRP.CN : 5.550 (+1.46%)
TREIF : 1.0400 (-5.27%)
AEZS.TO : 0.61 (-1.61%)
BB.TO : 12.59 (-3.38%)
APS.TO : 2.87 (-4.33%)
HEXO.TO : 1.47 (-4.55%)
3 Tech Stocks That Could Change The World

The mega-industries of energy, healthcare, and digital advertising aren’t just ripe for disruption ...

QS : 30.64 (-4.84%)
TM : 179.83 (-2.69%)
VWAGY : 29.2200 (-3.63%)
TTD : 103.98 (-2.10%)
DXD : 8.88 (+5.09%)
BB.TO : 12.59 (-3.38%)
CRH.TO : 4.99 (+0.40%)
AEZS.TO : 0.61 (-1.61%)
APS.TO : 2.87 (-4.33%)
Aptose to Present at September Investor Conferences

SAN DIEGO and TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying...

APTO : 2.28 (-5.00%)
APS.TO : 2.87 (-4.33%)
Aptose Reports Results for the Second Quarter 2021

- Conference call and webcast at 5:00 pm EDT today -

APTO : 2.28 (-5.00%)
APS.TO : 2.87 (-4.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 3.20
2nd Resistance Point 3.14
1st Resistance Point 3.00
Last Price 2.87
1st Support Level 2.80
2nd Support Level 2.74
3rd Support Level 2.60

See More

52-Week High 9.40
Fibonacci 61.8% 6.77
Fibonacci 50% 5.95
Fibonacci 38.2% 5.14
Last Price 2.87
52-Week Low 2.51

See More

Business Summary

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. CG026806...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar